News

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
Male Reddit users are reporting what they call "Ozempic penis," with some claiming penile growth of up to 1.5 inches. However ...
Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...
After three years, only about 1 in 12 individuals taking GLP-1s to treat obesity remained on the therapy, according to a Prime Therapeutics study published on June 25. Prime is owned by 19 Blue Cross ...